PT  - JOURNAL ARTICLE
AU  - Nichols, Emma Hitt
ED  - Cannon, Christopher P.
TI  - Ezetimibe Plus Statin Reduces CV Events after ACS
DP  - 2014  01
TA  - MD Conference Express
PG  - 17--18
VI  - 14
IP  - 52
4099  - http://mdc.sagepub.com/content/14/52/17.short
4100  - http://mdc.sagepub.com/content/14/52/17.full
AB  - Statins have been demonstrated to reduce morbidity and mortality; however, adding other lipid-modifying therapies to statin treatment has not demonstrated a clear benefit. This article presents data from the Improved Reduction of Outcomes: Vytorin (Ezetimibe/Simvastatin) Efficacy International Trial [IMPROVE-IT; NCT00202878]. The purpose of the IMPROVE-IT trial was to evaluate the clinical benefit of combination therapy with ezetimibe plus simvastatin compared with simvastatin monotherapy in lowering LDL-C levels.